Generated: December 18, 2017
DrugPatentWatch Database Preview
Maprotiline hydrochloride - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for maprotiline hydrochloride and what is the scope of maprotiline hydrochloride freedom to operate?
is the generic ingredient in two branded drugs marketed by Novartis, Am Therap, Mylan, Watson Labs, and Watson Labs Teva, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.
There are three drug master file entries for maprotiline hydrochloride. One supplier is listed for this compound.
Summary for maprotiline hydrochloride
Medical Subject Heading (MeSH) Categories for maprotiline hydrochloride
|Watson Labs||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||071943-001||Dec 30, 1987||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Novartis||LUDIOMIL||maprotiline hydrochloride||TABLET;ORAL||017543-003||Sep 30, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Am Therap||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||072129-001||Jan 14, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs Teva||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||072163-001||Jun 1, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||071944-001||Dec 30, 1987||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||071945-001||Dec 30, 1987||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Mylan||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||072285-003||Oct 3, 1988||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Am Therap||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||072131-001||Jan 14, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Novartis||LUDIOMIL||maprotiline hydrochloride||TABLET;ORAL||017543-002||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Mylan||MAPROTILINE HYDROCHLORIDE||maprotiline hydrochloride||TABLET;ORAL||072285-002||Oct 3, 1988||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.